Pharmacological differentiation of bimatoprost and latanoprost induced ocular hypotension by a second generation prostamide antagonist (AGN 211336)

Prostaglandins: Biochemistry, Functions, Types and Roles

Volumn , Issue , 2011, Pages 65-80

  Woodward, F David ^a   Liang, Yanbin ^a   Wang, W Jenny ^a   Li, Chen ^a   Guzman, M Victor ^a   Kharlamb, B Alexander ^a   Wheeler, A Larry ^a   Garst, E Michael ^a   Carling, W C Robert ^b   Cornell, L Clive ^b   Fliri, G Hans ^b   Martos, L Jose ^b   Pettit, N Simon ^b   Hopper, L David ^c   DiMarzo, Vincenzo ^d   Ortar, Giorgio ^e  

^a ALLERGAN INC   (United States)

^b Selcia Ltd   (United Kingdom)

^c BIOANALYTICAL SYSTEMS INC   (United States)

^d CNR   (Italy)

^e SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84873474942     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (24)

1. Arunlakshana, O. & Schild, H. O. (1959). Some quantitative use of drug antagonists. Br. J. Pharmacol. Chemother., 257, 48-58.
2. Boger, D. L., Miyauchi, H., Du, W., Hardovin, C., Fecik, R. A., Cheng, H., Hwang, I., Hendrick, M. P., Leung, D., Acevedo, O., Guimaraes, C. R. W., Jargensen, W. L. & Cravatt, B. F. (2005). Discovery of a potent, selective, and efficacious class of reversible -ketoheterocycle inhibitors of fatty acid amide hydrolase effective as analgesis. J. Med. Chem., 48, 1849-1856.
3. Chen, J., Champa-Rodriguez M. L. & Woodward, D. F. (1995). Identification of a Prostanoid FP receptor population producing endothelium-dependent vasorelaxation in the rabbit jugular vein. Br. J. Pharmacol., 116, 3035-3041.
4. Chen, J., Dinh, T., Woodward, D. F., Holland, J. M., Yuan, Y. D., Lin T. H. & Wheeler, L. A. (2005). Bimatoprost: mechanism of ocular surface hyperemia associated with topical therapy. Cardovasc. Drug Rev., 23, 231-246.
5. Chen, J., Senior, J., Marshall, K., Abbass, F., Dinh, H., Dinh, T., Wheeler, L. A. & Woodward, D. F. (2005a). Studies using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have different activity profiles. Br. J. Pharmcol., 144, 493-501.
6. Chen, J., Dinh, T., Woodward, D. F., Holland, J. M., Yuan, Y. D., Lin, T. H. & Wheeler, L. A. (2005b). Bimatprost: mechanism of ocular surface hyperemia associated with topical therapy. Cardiovasc. Drug Rev., 23, 231-246.
7. Crouston, J. G., Lindsey, J. D., Morris, C. A., Wheeler, L., Medeinos, F. A. & Weinreb, R. N. (2005). Effect of bimatoprost on intraocular pressure in prostaglandin FP receptor knockout mice. Invest. Ophthalmol. Vis. Sci., 46, 4571-4577.
8. Gandolfi, S. A. & Cimino, L. (2003). Effect of bimatoprost on patients with primary openangle glaucoma on ocular hypertension who are nonresponders to latanoprost. Ophthalmol., 110, 609-614.
9. 2α (FP) receptor. J. Pharmacol. Exp. Ther., 290, 1278-1284.
10. 2 agonist) on Cyr 61 and CTGF gene expression. J. Biol. Chem., 278, 27267-27277.
11. 2α, bimatoprost and butaprost treatments. Essential role of a protein kinase C pathway involved in the EP2 receptor activated Nur 77 gene transcription. Br. J. Pharmacol., 142, 737-748.
12. Liang, Y., Woodward, D. F., Guzman, V. M., Li, C., Scott, D. F., Wang, J. W., Wheeler, L. A., Garst, M. E., Landsverk, K., Sachs, G., Krauss, A. H. P., Cornell, C., Martos, J., Pettit, S. & Fliri, H. (2008). Isolation and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes. Br. J. Pharmacol., 154, 1079-1093.
13. Lichtman, A. H., Leung, D., Shelton, C., Saghatelian, A., Hardovin, C., Boger, D. L. & Cravatt, B. F. (2004). Reversible inhibitors of fatty acid amide hydrolase that promote analgesia: evidence for an unprecedented combination of potency and selectivity. J. Pharmacol. Exp. Ther., 311, 441-448.
14. Matias, I., Chen, J., De Petrocellis, L., Bisogno, T., Ligresti, A.,Fezza, F., Krauss, A. H. P. Shi, L., Protzman, C. E., Li, C., Liang, Y., Nieves, A. L., Kedzie, K. M., Burk, R. M., Di Marzo, V. & Woodward, D. F. (2004). Prostaglandin ethanolamides (prostamides) = in vitro pharmacology and metabolism. J. Pharmacol. Exp. Ther., 309, 745-757.
15. Maxwell, W. A., Reiser, H. J., Stewart, R. H., Cavanagh, H. D., Walters, T. R., Sager, D. P. & Meuse, P. A. (2008). the Nepafenac Study Group Nepafenac dosing frequency for ocular pain and inflammation associated with cataract surgery. J. Ocular Pharmacol., Ther., 24, 593-599.
16. Ota, T., Aihara, M., Narumiya, S. & Araie, M. (2005). The effects of prostaglandin analogues on IOP in prostanoid FP receptor-deficient mice. Invest. Ophthalmol., Vis. Sci., 46, 4159- 4163.
17. Richter, M., Krauss, A. H., Woodward, D. F. & Lutjen-Drecoll, E. (2003). Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide. Invest. Ophthalmol. Vis. Sci., 44, 4419-4426.
18. 2α selectively stimulate intracellular calcium signaling in different cat iris sphincter cells. Exp. Eye Res., 80, 135-145.
19. Wan, Z., Woodward, D. F., Cornell, C. L., Fliri, H. G., Martos, J. L., Pettit, S. N., Wang, J. W., Kharlamb, A. B., Wheeler, L. A., Garst, M. E., Landsverk, K. J. Struble, C. S. & Stamer, W. D. (2007). Bimatoprost, prostamide activity, and conventional drainage. Invest. Ophthalmol. Vis. Sci., 48, 4107-4115.
20. Woodward, D. F., Krauss, A. H. P., Chen, J., Liang, Y., Li, C., Protzman, C.E., Bogardus, A., Chen, R., Kedzie, K. M., Krauss, H. A., Gil, D. W., Kharlamb, A., Wheeler, L. A., Babusis, D., Welty, D., Tang-Liu, D. D. S., Cherkury, M., Andrews, S. W., Burk, R. M. & Garst, M. E. (2003). Pharmacological characterizations of a novel antiglaucoma agent, bimatoprost (AGN 192024). J. Pharmacol. Exp. Ther., 305, 772-785.
21. Woodward, D. F., Phelps, R. L., Krauss, A. H. P., Weber, A., Short, B., Chen, J., Liang, Y., Wheeler, L. A. (2004). Bimatoprost: a novel anti-glaucoma agent. Cardiovasc. Drug Rev., 22, 103-120.
22. Woodward, D. F., Krauss, A. H. P., Wang, J. W., Protzman, C. E., Nieves, A. L., Liang, Y., Donde, Y., Burk, R. M., Landsverk, K. & Struble, C. (2007a). Br. J. Pharmacol., 150, 342-352.
23. Woodward, D. F., Liang, Y. & Krauss, A. H. P. (2008). Prostamides (prostaglandinethanolamides) and their pharmacology. Br. J. Pharmacol., 153, 410-419.
24. Woodward, D. F., Carling, R. W. C., Cornell, C. L. Fliri H. G., Martos, J. L., Liang, Y. & Wang J. W. (2008b). The Pharmacology and Therapeutic relecvance of endocannabinoid derived cyclo-oxygenase (COX) -2 products. Pharmacol., Ther, in press.